Viewing Study NCT02289495


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-22 @ 9:37 AM
Study NCT ID: NCT02289495
Status: TERMINATED
Last Update Posted: 2017-05-09
First Post: 2014-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infection, Human Immunodeficiency Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Single Dose Escalation View
None Repeat Dose Escalation View
None GSK2838232 View
None Ritonavir View